BOSTON, April 23, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Abeona Therapeutics, Inc. (NASDAQ:ABEO) for potential securities law violations. Investors who have lost money in their Abeona Therapeutics, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/abeo.
What is this all about?
Shares of Abeona Therapeutics plunged more than 45% in early morning trading on April 23 after the Company disclosed receiving a Complete Response Letter from the U.S. Food and Drug Administration for its lead clinical program pz-cel.
Who is eligible?
Anyone who purchased Abeona Therapeutics, Inc. common stock and has seen their shares fall may be eligible, whether or not they have ...